These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37695458)

  • 1. Growing Deficit in New Cancer Diagnoses 2 Years Into the COVID-19 Pandemic: A National Multicenter Study.
    Englum BR; Sahoo S; Mayorga-Carlin M; Hayssen H; Siddiqui T; Turner DJ; Sorkin JD; Lal BK
    Ann Surg Oncol; 2023 Dec; 30(13):8509-8518. PubMed ID: 37695458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on diagnosis of new cancers: A national multicenter study of the Veterans Affairs Healthcare System.
    Englum BR; Prasad NK; Lake RE; Mayorga-Carlin M; Turner DJ; Siddiqui T; Sorkin JD; Lal BK
    Cancer; 2022 Mar; 128(5):1048-1056. PubMed ID: 34866184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the COVID-19 Pandemic With Rates of Prostate Cancer Biopsies and Diagnoses in Black vs White US Veterans.
    Klaassen Z; Stock S; Waller J; De Hoedt A; Freedland SJ
    JAMA Oncol; 2022 Jun; 8(6):914-918. PubMed ID: 35389461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.
    Burus T; Lei F; Huang B; Christian WJ; Hull PC; Ellis AR; Slavova S; Tucker TC; Lang Kuhs KA
    JAMA Oncol; 2024 Apr; 10(4):500-507. PubMed ID: 38386344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Cancer Diagnoses Before and During the COVID-19 Pandemic.
    Decker KM; Feely A; Bucher O; Czaykowski P; Hebbard P; Kim JO; Pitz M; Singh H; Thiessen M; Lambert P
    JAMA Netw Open; 2023 Sep; 6(9):e2332363. PubMed ID: 37669049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.
    Tran C; Cipriano LE; Driman DK
    CMAJ Open; 2023; 11(3):E475-E484. PubMed ID: 37279981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Prostate-Specific Antigen Testing and Prostate Biopsies During the COVID-19 Pandemic.
    Kaufman HW; Chen Z; Niles JK; Radcliff J; Fesko Y
    JCO Clin Cancer Inform; 2021 Sep; 5():1028-1033. PubMed ID: 34648367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
    Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
    BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations.
    Concepcion J; Yeager M; Alfaro S; Newsome K; Ibrahim J; Bilski T; Elkbuli A
    Am Surg; 2023 Jun; 89(6):2276-2283. PubMed ID: 35420510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.
    Lowry KP; Bissell MCS; Miglioretti DL; Kerlikowske K; Alsheik N; Macarol T; Bowles EJA; Buist DSM; Tosteson ANA; Henderson L; Herschorn SD; Wernli KJ; Weaver DL; Stout NK; Sprague BL
    Radiology; 2022 May; 303(2):287-294. PubMed ID: 34665032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study.
    Barclay NL; Pineda Moncusí M; Jödicke AM; Prieto-Alhambra D; Raventós B; Newby D; Delmestri A; Man WY; Chen X; Català M
    Front Oncol; 2024; 14():1370862. PubMed ID: 38601756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta.
    Heer E; Ruan Y; Boyne DJ; Jarada TN; Heng D; Henning JW; Morris DM; O'Sullivan DE; Cheung WY; Brenner DR
    CMAJ; 2023 Jun; 195(23):E804-E812. PubMed ID: 37308211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed Colorectal Cancer Diagnosis during the COVID-19 Pandemic in Alberta: A Framework for Analyzing Barriers to Diagnosis and Generating Evidence to Support Health System Changes Aimed at Reducing Time to Diagnosis.
    Walker E; Fu Y; Sadowski DC; Stewart D; Tang P; Kaposhi B; Chappell H; Robson P; Veldhuyzen van Zanten S
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 on hospital screening, diagnosis and treatment activities among prostate and colorectal cancer patients in Canada.
    Lee SH; Ojo AT; Halat M; Bleibdrey N; Zhang S; Chalmers R; Zimskind D
    Int J Health Econ Manag; 2023 Sep; 23(3):345-360. PubMed ID: 37005943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.
    Han X; Yang NN; Nogueira L; Jiang C; Wagle NS; Zhao J; Shi KS; Fan Q; Schafer E; Yabroff KR; Jemal A
    Lancet Oncol; 2023 Aug; 24(8):855-867. PubMed ID: 37541271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.
    Peacock HM; Tambuyzer T; Verdoodt F; Calay F; Poirel HA; De Schutter H; Francart J; Van Damme N; Van Eycken L
    ESMO Open; 2021 Aug; 6(4):100197. PubMed ID: 34474811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals.
    El-Zein M; Ali R; Farah E; Botting-Provost S; Franco EL;
    Elife; 2023 Jun; 12():. PubMed ID: 37377399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.